Recent 8-K filings for OXBR
Highest-materiality recent filing
Oxbridge Re Q2 net loss $1.87M; loss ratio 394% from Hurricane Milton
- Net loss for Q2 2025: $1.87M ($0.25 per share) vs $821K ($0.14) in Q2 2024; six-month loss $2.01M ($0.28).
- Loss ratio surged to 394% due to $2.29M full limit loss from Hurricane Milton on one reinsurance contract.
-
Oxbridge Re Q1 net income $22k; tokenized reinsurance tokens target 25% and 42% returns
Net income of $22k (vs loss of $139k YoY); net premiums earned $555k, down from $595k.
-
Oxbridge Re Q4 net income $120K, full-year loss narrows; token returns beat targets
Q4 2025 net income $120K ($0.02/share) vs net loss $460K ($0.05 loss/share) year ago.
-
Oxbridge Re borrows $1M at 16% rate, secures with all assets via 6-month note
$1M principal borrowed from Real World Digital Assets LLC; 6-month maturity through Aug 14, 2026.
-
Oxbridge Re subsidiary launches $20M tokenized participation share offering
SurancePlus Inc. offering up to 2,000,000 Participation Shares at $10 each via digital tokens T20-2027 and T42-2027.
-
Oxbridge Re Q3 net loss narrows to $187K; expenses surge; token yields exceed targets
Net loss per share ($0.02) improved from ($0.09) YoY; net premiums earned $555K vs $595K.
-
Oxbridge Re files prospectus supplement for up to $2.02M in share sales under ATM program
Filed prospectus supplement to S-3 (333-287186) for sale of up to $2,021,889 of ordinary shares.
-
Authorized shares increased from 50M to 500M (450M new shares) via amendment to Memorandum and Articles, effective immediately.
-
Oxbridge Re Q2 net loss $1.87M; loss ratio 394% from Hurricane Milton
Net loss for Q2 2025: $1.87M ($0.25 per share) vs $821K ($0.14) in Q2 2024; six-month loss $2.01M ($0.28).
-
Oxbridge Re enters ATM equity offering agreement for up to $5M with Maxim Group
Equity Distribution Agreement with Maxim Group to sell up to $5M ordinary shares at-the-market.
-
Oxbridge Re shareholders approve issuance of >19.99% of shares on Series B warrants
Five director nominees elected: Madhu, Gowda, Merren, Timothy, Thompson; each with >2.5M votes for.
-
Net loss of $139K ($0.02 per share) vs $905K loss ($0.15) in Q1 2024.
-
Oxbridge Re reports FY 2024 net loss of $2.7M, improved from $9.9M; premiums up 83%
Net loss $2.7M ($0.45/share) vs $9.9M ($1.69) prior year; Q4 net loss $460K vs $2.67M prior year.
-
Up to 1M Participation Shares at $10 each; discounts of 5%/10% for investments >$50K/$100K.
-
Oxbridge Re raises $3.0M via registered direct offering and warrants issuance
Sold 705,884 ordinary shares, 529,413 Series A warrants, and 882,355 Series B warrants at $4.25 combined effective price.
-
SurancePlus Holdings Ltd. offers up to $5 million of its ordinary shares to accredited investors under Rule 506(c) and Regulation S.
-
Oxbridge Re discloses max $1.7M potential hurricane loss; no claims yet
No claims received from ceding insurers related to Hurricanes Helene and Milton.
-
Oxbridge Re Q3 net loss narrows to $540K from $7.3M; new token offerings planned
Net loss of $540K ($0.09/share) vs $7.3M ($1.24) in Q3 2023; nine-month loss $2.27M vs $7.2M.
-
Oxbridge Re Q2 net loss $821K; completes $2.88M tokenized reinsurance placement
Net loss $821K ($0.14 per share) for Q2 2024 vs net loss $85K ($0.01) in Q2 2023; year-to-date net loss $1.73M vs net profit $57K prior year.
-
287,705 Participation Shares sold at $10.00 each for gross proceeds of $2,878,048.
-
Oxbridge Re Holdings holds 2024 AGM; elects directors and ratifies auditor
Five director nominees elected: Sanjay Madhu, Arun Gowda, Dwight Merren, Wrendon Timothy, Lesley Thompson.
-
Oxbridge Re evaluates strategic alternatives including sale or merger
Board formed Special Committee to explore strategic alternatives for Co. and/or Web-3 unit SurancePlus Holdings.
-
Oxbridge Re Q1 net loss $905K vs net income $142K; premiums earned $549K
Net loss of $905K (($0.15) per share) vs net income $142K ($0.02) in Q1 2023.
-
Oxbridge Re subsidiary SurancePlus launches $3M private placement; 500K parent warrants offered
SP Holdings offering up to $3,000,000 of its ordinary shares in private placement.
-
Oxbridge Re subsidiary adopts 2024 equity plan; grants restricted shares and options to executives
SPH 2024 Equity Incentive Plan adopted, reserving 750,000 SPH ordinary shares for awards.
-
Oxbridge Re FY2023 net loss widens to $9.9M; tokenized reinsurance returns >45%
Net loss of $9.9M ($1.69/share) for FY2023 vs $1.8M ($0.31/share) loss in prior year.
-
SurancePlus, Oxbridge Re subsidiary, commenced offering of up to 1,000,000 Participation Shares at $10 per share, represented by digital tokens 'EpsilonCat Re'.
Earnings & guidance
Materiality & sentiment trend
Max materiality 0.75 · Median 0.57 · Most common event other_material